Nyrada Inc Annual General Meeting Presentation

“Our strategy is to advance highly optimised drug candidates towards a key value inflection point , such
as an efficacy signal, and out licence them early , where the risk reward equation is most favourable
for Nyrada shareholders”

Nyrada Inc AGM Presentation